Surgical Outcomes Research| Volume 128, ISSUE 5, P865-867, November 2000

Download started.


Invited commentary: Early-stage breast cancer treatment for elderly women—does one size fit all?


      Surgery 2000;128:865-7.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Mor V
        • Laliberte LL
        • Petrisek AC
        • et al.
        Impact of breast cancer treatment guidelines on surgeon practice patterns: results of a hospital-based intervention.
        Surgery. 2000; 128: 847-861
        • Hortobagyi GN
        • Buzdar AU
        Current status of adjuvant systemic therapy for primary breast cancer: progress and controversy.
        CA Cancer J Clin. 1995; 45: 199-226
        • Taghian AG
        • Powell SN
        The role of radiation therapy for primary breast cancer.
        Surg Clin North Am. 2000; 79: 1091-1115
        • Welch H
        • Albertsen P
        • Nease R
        • et al.
        Estimating treatment benefits for the elderly: the effect of competing risks.
        Ann Intern Med. 1996; 124: 577-584
        • Petrisek A
        • Laliberte L
        • Allen S
        • et al.
        The treatment decision-making process: age differences in a sample of women recently diagnosed with nonrecurrent, early-stage breast cancer.
        Gerontologist. 1997; 37: 598-608
        • Kolata G.
        New emphasis in cancer drug tests: the elderly.
        New York Times. 2000 February 15; (Sect. C): 1
        • Mehl A.
        Physician autonomy, patient choice, and immunization performance measures.
        Eff Clin Pract. 1999; 2: 289-293
        • Schwartz L
        • Woloshin S
        • Welch H.
        Risk communication in clinical practice: putting cancer in context.
        J Natl Cancer Inst Monogr. 1999; 25: 124-133
        • O'Connor A
        • Rostom A
        • Fiset V
        • et al.
        Decision aids for patients facing health treatment or screening decisions: systematic review.
        BMJ. 1999; 319: 731-734
        • Crivellari D
        • Bonetti M
        • Castiglione-Gertsch M
        • et al.
        Burdens and benefits of adjuvant cyclophosphamide, methotrexate, and fluorouracil and tamoxifen for elderly patients with breast cancer: the international breast cancer study group trial VII.
        J Clin Oncol. 2000; 18: 1412-1422